The use of antipsychotics in preschoolers: a veto or a sensible last option?

Area of Science:

• Pediatric Pharmacology
• Child Psychiatry
• Evidence-Based Medicine

Background:

• Antipsychotic medications, developed for adults, are increasingly prescribed for preschool children.
• This trend raises concerns regarding off-label use and potential risks in a vulnerable population.

Purpose of the Study:

• To review current antipsychotic usage in preschoolers.
• To compare this usage with official guidelines and licensing.
• To evaluate the evidence for efficacy, safety, and long-term risks.

Main Methods:

• Literature review of antipsychotic use in preschool children.
• Analysis of diagnostic trends and comparison with prescribing guidelines.
• Assessment of the evidence base for efficacy and adverse events.

Main Results:

• Significant rise in antipsychotic prescriptions for preschool-aged children.
• Limited evidence supports efficacy for many conditions in this age group.
• Compelling evidence indicates increased adverse events and potential long-term neurodevelopmental risks.

Conclusions:

• Current antipsychotic use in preschoolers is controversial due to a lack of supporting evidence and significant safety concerns.
• There is a critical gap in research regarding the risks and benefits of these medications in young children.
• Clinical practice requires pragmatism, acknowledging limited evidence and potential harm, necessitating further research and guideline development.